Paperpal Prime Logo

Theranostics : Impact Factor & More

eISSN: 1838-7640pISSN: 1838-7640
JournalOpen Access

Key Metrics

CiteScore
16.7
Impact Factor
10 - 15
Scite Index
0.93 5-Year SI
SJR
Q1Medicine (miscellaneous)
SNIP
1.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Theranostics

Theranostics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher IVYSPRING INT PUBL
Language English
Frequency Irregular
Article Processing ChargesAUD 2500
Publication Time12
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyIrregular
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Theranostics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Theranostics

A robust asymmetric bioadhesive patch for sutureless intestinal repair to prevent anastomotic leakage and postoperative adhesion.
  • 17 Jun 2026
  • Theranostics
Beyond catalysis: Spatial topology of GPX4 in ferroptosis and its theranostic implications
  • 26 May 2026
  • Theranostics
EcPICK: A deep learning-enabled spatial diagnostic platform for direct ecDNA identification and clinical prognosis across pan-cancer histopathology
  • 25 May 2026
  • Theranostics
Stimuli-responsive nanomaterials for wound healing: advances and emerging directions
  • 18 May 2026
  • Theranostics
BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage\u2013myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis
  • 18 May 2026
  • Theranostics
Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment
  • 18 May 2026
  • Theranostics
A robust asymmetric bioadhesive patch for sutureless intestinal repair to prevent anastomotic leakage and postoperative adhesion.
  • 17 Jun 2026
  • Theranostics
Beyond catalysis: Spatial topology of GPX4 in ferroptosis and its theranostic implications
  • 26 May 2026
  • Theranostics
EcPICK: A deep learning-enabled spatial diagnostic platform for direct ecDNA identification and clinical prognosis across pan-cancer histopathology
  • 25 May 2026
  • Theranostics
Stimuli-responsive nanomaterials for wound healing: advances and emerging directions
  • 18 May 2026
  • Theranostics
BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage\u2013myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis
  • 18 May 2026
  • Theranostics
Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment
  • 18 May 2026
  • Theranostics

FAQs on Theranostics